GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OCSE:EMBLA) » Definitions » Capital Expenditure

Embla Medical hf (OCSE:EMBLA) Capital Expenditure : kr-234.53 Mil (TTM As of Mar. 2025)


View and export this data going back to 2009. Start your Free Trial

What is Embla Medical hf Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Embla Medical hf's cash flow for capital expenditures for the three months ended in Mar. 2025 was kr-43 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2025 was kr-234.53 Mil.

Embla Medical hf Capital Expenditure Historical Data

The historical data trend for Embla Medical hf's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Capital Expenditure Chart

Embla Medical hf Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -146.90 -175.63 -182.19 -288.96 -279.38

Embla Medical hf Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -78.78 -75.49 -59.47 -57.00 -42.58

Embla Medical hf Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-234.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Embla Medical hf Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OCSE:EMBLA) » Definitions » Capital Expenditure
Comparable Companies
OCSE:GN OCSE:CHEMM OCSE:SMSMED OCSE:VIRO OCSE:AMBU B OCSE:DEMANT ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD XAMS:PHIA XSWX:SOON ZBH SHSE:688271
Traded in Other Exchanges
OSSUY:USA 0FIW:UK
Address
Grjothals 5, Reykjavik, ISL
Website
https://www.emblamedical.com
Embla Medical hf is is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. Embla Medical operates within three business segments of the non-invasive orthopedics market; Prosthetics and Neuro Orthotics; Bracing and Supports; and Patient Care. Key revenue is generated from Prosthetics and Neuro Orthotics; segment.

Embla Medical hf Headlines

No Headlines